u/dead_space_doug

Cosigning. The slow route gets the outcome, the fast route gets you the side effects.

Batch number and date of analysis?

Adding to this: purity is doing more work than the comment implies.

Strongly agree. Escrow is non-negotiable for groups.

Water content was 3.8%, acetate was 6.2%, purity was 99%, but net peptide was only 90% of the label weight. Perfectly honest, just chemistry.

pens are overpriced, research vials are research grade, same molecule different price

Crossposting this to c/glp1eu because the people who need it are not reading this community.

Strongly agree. Mass% and area% are answering different questions on the same document.

Every time this gets posted it hits the front page and every time someone has to re-explain it.

Yeah, the chromatogram profile matters more than the headline number.

a round-robin on baseline integration would be genuinely useful

gas versus discount arithmetic is real

nope, 0.25 counts, it is just not the dose most people stay on

the boring consistency is the point

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

The glucagon component does different things than dual agonism.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual

escrow for group buys is standard, use it

Titration speed is a side-effect dial far more than an efficacy dial.

long-running logs are the value

Strongly agree. Update rather than repost.

Sceptical. If this were true we would see it reflected in the data and we do not.